REFERENCIAS

1. Espinosa F, Reyes O. Depresio´n posparto en pacientes de bajo riesgo atendidas en la Maternidad del Hospital Santo Toma´s, Panama´. Estudio prospectivo. Rev centroam Obstet Ginecol. 2020;24(1):2-9. DOI: 10.37980/im.journal.revcog.2020867 [ Links ]

2. van Niel MS, Payne JL. Perinatal depression: A review. Cleveland Clin J Med [Internet]. 2020 May 1;87(5):273-7. DOI: 10.3949/ccjm.87a.19054 [ Links ]

3. Mackiewicz Seghete KL, Graham AM, Lapidus JA, Jackson ELA, Doyle OJ, Feryn AB, et al. Protocol for a mechanistic study of Mindfulness Based Cognitive Therapy during pregnancy. Health Psychol [Internet]. 2020 Sep 1 [cited 2022 Jul 4];39(9):758. DOI: 10.1037/hea0000870 [ Links ]

4. Payne JL, Maguire J. Pathophysiological mechanisms implicated in postpartum depression. Front Neuroendocrinol. 2019 Jan 1;52:165-80. DOI: 10.1016/j.yfrne.2018.12.001 [ Links ]

5. Brown JVE, Wilson CA, Ayre K, Robertson L, South E, Molyneaux E, et al. Antidepressant treatment for postnatal depression. Cochrane Database of Systematic Reviews. 2021 Feb 13;2021(2). DOI: https://doi.org/10.1002/14651858.CD013560.pub2 [ Links ]

6. Meltzer-Brody S, Stuebe A. The long-term psychiatric and medical prognosis of perinatal mental illness. Best Pract Res Clin Obstet Gynaecol. 2014 Jan 1;28(1):49-60. DOI: 10.1016/j. bpobgyn.2013.08.009 [ Links ]

7. Chorwe-Sungani G, Chipps J. A systematic review of screening instruments for depression for use in antenatal services in low resource settings. BMC Psychiatry [Internet]. 2017 Mar 24 [cited 2022 Aug 9];17(1). DOI: 10.1186/s12888-017-1273-7 [ Links ]

8. Becker M, Weinberger T, Chandy A, Schmukler S. Depression During Pregnancy and Postpartum. Current Psychiatry Reports. 2016;18:3 [Internet]. 2016 Feb 15 [cited 2022 Jul 18];18(3):1-9. DOI: 10.1007/s11920-016-0664-7 [ Links ]

9. Ghaedrahmati M, Kazemi A, Kheirabadi G, Ebrahimi A, Bahrami M. Postpartum depression risk factors: A narrative review. J Educ Health Promot [Internet]. 2017 [cited 2023 Feb 8];6:60. DOI: 10.4103/jehp.jehp_9_16 [ Links ]

10. Iliadis SI, Skalkidou A, Ranstrand H, Georgakis MK, Axfors C, Papadopoulos FC. Self-Harm Thoughts Postpartum as a Marker for Long-Term Morbidity. Front Public Health. 2018 Feb 19;6:34. DOI: 10.3389/fpubh.2018.00034 [ Links ]

11. Solís Solano M, Pineda Mejía AL, Chacón Madrigal J. Abordaje clínico y manejo de la depresión posparto. Rev Medica Sinerg [Internet]. 2019;4(6):90-9. http://dx.doi.org/10.31434/rms. v4i6.248 [ Links ]

12. Stewart DE, Vigod SN. Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics. 2019 Jan 28 [cited 2022 Aug 10];70:183-96. DOI: 10.1146/annurev-med-041217-011106 [ Links ]

13. Dominiak M, Antosik-Wojcinska AZ, Baron M, Mierzejewski P, Swiecicki L. Recommendations for the prevention and treatment of postpartum depression. Ginekol Pol [Internet]. 2021 [cited 2022 Jul 3];92(2):153-64. DOI: 10.5603/GP.a2020.0141 [ Links ]

14. Schipper-Kochems S, Fehm T, Bizjak G, Fleitmann AK, Balan P, Hagenbeck C, et al. Postpartum Depressive Disorder - Psychosomatic Aspects. Geburtshilfe Frauenheilkd [Internet]. 2019 [cited 2022 Aug 15];79(4):375. DOI: 10.1055/a-0759-1981 [ Links ]

15. Ahmadpanah M, Nazaribadie M, Aghaei E, Ghaleiha A, Bakhtiari A, Haghighi M, et al. Influence of adjuvant detached mindfulness and stress management training compared to pharmacologic treatment in primiparae with postpartum depression. Arch Women's Mental Health. 2017;21:1 [Internet]. 2017 Jul 18 [cited 2022 Jul 3];21(1):65-73. DOI: 10.1007/s00737-017-0753-6 [ Links ]

16. Ukatu N, Clare CA, Brulja M. Postpartum Depression Screening Tools: A Review. Psychosomatics [Internet]. 2018 May 1 [cited 2022 Jul 3];59(3):211-9. DOI: 10.1016/j.psym.2017.11.005 [ Links ]

17. Kroska EB, Stowe ZN. Postpartum Depression Identification and Treatment in the Clinic Setting. Obstet Gynecol Clin North Am. 2020 Sep;47(3):409-19. doi: 10.1016/j.ogc.2020.05.001 [ Links ]

18. Gaviria-Arbeláez SL, Uribe-Holguín A, Gil-Castaño LS, Uribe-Bravo SE, Serna-Galeano LE, Álvarez-Mesa C, et al. Prevalencia del riesgo de depresión y preocupaciones en mujeres gestantes en el contexto de la pandemia por COVID-19 en Antioquia, Colombia, 2020-2021. Rev Colomb Obstet Ginecol [Internet]. 2022;73(2):194-202. http://dx.doi.org/10.18597/rcog.3821 [ Links ]

19. Chen Q, Li W, Xiong J, Zheng X. Prevalence and Risk Factors Associated with Postpartum Depression during the COVID-19 Pandemic: A Literature Review and Meta-Analysis. Int J Environ Res Public Health [Internet]. 2022 Feb 1 [cited 2022 Aug 15];19(4):2219. DOI: 10.3390/ijerph19042219 [ Links ]

20. Hantsoo L, Ward-O'Brien D, Czarkowski KA, Gueorguieva R, Price LH, Epperson CN. A Randomized, Placebo-Controlled, Double-Blind Trial of Sertraline for Postpartum Depression. Psychopharmacology (Berl) [Internet]. 2014 Mar [cited 2022 Aug 10];231(5):939. DOI: 10.1007/s00213-013-3316-1 [ Links ]

21. O'Hara MW, Engeldinger J. Treatment of Postpartum Depression: Recommendations for the Clinician. Clin Obstet Gynecol [Internet]. 2018 Sep 1 [cited 2022 Jul 3];61(3):604-14. DOI: 10.1097/GRF.0000000000000353 [ Links ]

22. Cuomo A, Maina G, Neal SM, De Montis G, Rosso G, Scheggi S, et al. Using sertraline in postpartum and breastfeeding: balancing risks and benefits. Expert Opin Drug Saf [Internet]. 2018 Jul 3 [cited 2022 Jul 3];17(7):719-25. DOI: 10.1080/14740338.2018.1491546 [ Links ]

23. Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psych. 2004 Jun;161(6):1066-78. DOI: 10.1176/appi.ajp.161.6.1066 [ Links ]

24. Olsen RW, Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacol [Internet]. 2009 Jan [cited 2023 Mar 15];56(1):141-8. DOI: 10.1016/j. neuropharm.2008.07.045 [ Links ]

25. Saripalli A, Amar P, Duffee LE, Clayton AH. GABA-A Receptor Positive Allosteric Modulators as a Novel Approach to Treating Depression: A Review of Available Data. Neurology. 2021;17(2):77. DOI: https://doi.org/10.17925/USN.2021.17.2.77 [ Links ]

26. Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet [Internet]. 2017 Jul 29 [cited 2023 Mar 15];390(10093):480-9. DOI: 10.1016/S0140-6736(17)31264-3 [ Links ]

27. Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, et al. Brexanolone Injection in Postpartum Depression: 2 Multicenter, Double-blind, Randomized, Placebo-controlled Phase 3 Trials. Obstetric Anesthesia Digest [Internet]. 2019 Jun [cited 2023 Mar 15];39(2):87-8. DOI: 10.1016/S0140-6736(18)31551-4 [ Links ]

28. Walton N, Maguire J. Allopregnanolone-based treatments for postpartum depression: Why/how do they work? Neurobiol Stress. 2019 Nov 1;11:100198. DOI: 10.1016/j.ynstr.2019.100198 [ Links ]

29. Brandon AR, Crowley SK, Gordon JL, Girdler SS. Nonpharmacologic Treatments for Depression Related to Reproductive Events. Vol. 16, Current Psychiatry Reports. Current Medicine Group LLC 1; 2014. DOI: 10.1007/s11920-014-0526-0 [ Links ]

30. Dimidjian S, Goodman SH, Felder J, Gallop R, Brown AP, Beck A. Staying Well during Pregnancy and the Postpartum: A Pilot Randomized Trial of Mindfulness Based Cognitive Therapy for the Prevention of Depressive Relapse/Recurrence HHS Public Access. J Consult Clin Psychol. 2016;84(2):134-45. DOI: 10.1037/ccp0000068 [ Links ]

31. Taylor BL, Cavanagh K, Strauss C. The Effectiveness of Mindfulness-Based Interventions in the Perinatal Period: A Systematic Review and Meta-Analysis. PLoS One. 2016;11(5):155720. DOI: 10.1371/journal.pone.0155720 [ Links ]

32. Spijkerman MPJ, Pots WTM, Bohlmeijer ET. Effectiveness of online mindfulness-based interventions in improving mental health: A review and meta-analysis of randomised controlled trials. Clin Psychol Rev. 2016 Apr 1;45:102-14. DOI: https://doi. org/10.1016/j.cpr.2016.03.009 [ Links ]

33. Bulut S, Gümüssoy B. Postpartum Depression and Cognitive Behavioral Therapy from Face to Face Group Sessions to Online Group Sessions. DOI:10.31031/PPRS.2020.03.000581 [ Links ]

34. Milgrom J, Gemmill AW, Ericksen J, Burrows G, Buist A, Reece J. Treatment of postnatal depression with cognitive behavioural therapy, sertraline and combination therapy: A randomised controlled trial. Australian and New Zealand Journal of Psychiatry [Internet]. 2015 Mar 25 [cited 2022 Aug 10];49(3):236-45. DOI: 10.1177/0004867414565474 [ Links ]

35. Sockol LE. A systematic review of the efficacy of cognitive behavioral therapy for treating and preventing perinatal depression. J Affect Disord. 2015 May 15;177:7-21. DOI: 10.1016/j. jad.2015.01.052 [ Links ]

36. Committee on Clinical Practice Guidelines-Obstetrics. Screening and Diagnosis of Mental Health Conditions during Pregnancy and Postpartum. Obstet Gynecol 2023 June 6;141:1232-61. DOI: 10.1097/AOG.0000000000005200 [ Links ]